$ AAPL

$ ABBV

$ ABNB

$ ACGL

$ ADI

$ ADM

$ ADP

$ ADSK

$ AEE

$ AEP

$ AES

$ AFL

$ AIG

$ AIZ

$ AJG

$ AKAM

$ ALB

$ ALGN

$ ALL

$ AMAT

$ AMCR

$ AMD

$ AME

$ AMGN

$ AMP

$ AMT

$ AMZN

$ ANET

$ AOS

$ APA

$ APD

$ APO

$ APTV

$ ARE

$ ATO

$ AVB

$ AWK

$ AXON

$ BA

$ BALL

$ BAX

$ BBY

$ BDX

$ BEN

$ BG

$ BIIB

$ BKNG

$ BLDR

$ BMY

$ BR

$ BRO

$ BXP

$ CAG

$ CAH

$ CARR

$ CAT

$ CBOE

$ CBRE

$ CCL

$ CDNS

$ CDW

$ CEG

$ CF

$ CHD

$ CHRW

$ CI

$ CINF

$ CL

$ CLX

$ CMCSA

$ CMG

$ CMI

$ CMS

$ COIN

$ COO

$ COP

$ COR

$ CPAY

$ CPT

$ CRL

$ CRWD

$ CSCO

$ CTRA

$ CTSH

$ CTVA

$ CVS

$ CVX

$ CZR

$ DAL

$ DASH

$ DAY

$ DD

$ DDOG

$ DE

$ DELL

$ DG

$ DGX

$ DIS

$ DOC

Axon Enterprise posted strong Q2 revenue growth and raised guidance, but margin pressures and negative cash flow from high stock-based compensation and tariff risks temper the outlook.

# Axon Enterprise Delivers Robust Q2 2025 Revenue Beat and Raises Guidance, But Margin Pressures Emerge

---

## Executive Summary

- **Axon Enterprise (AXON) delivered a strong Q2 2025, with revenue of $669M (+33% YoY), beating consensus and driven by broad-based volume expansion.** Software & Services revenue surged 39% YoY, and Connected Devices grew 29% YoY, underpinned by record bookings and the largest deal in company history.
- **Profitability was mixed:** Adjusted gross margin improved to 63.3% (+20 bps YoY), and Software & Services margin reached 75.6% (+150 bps), but overall gross margin slipped 40 bps. Heavy stock-based compensation ($139M) led to an operating loss and negative operating/free cash flow, highlighting cost pressures despite internal AI-driven efficiencies.
- **Management struck a bullish tone, raising full-year revenue guidance to $2.65B–$2.73B and adjusted EBITDA to $665M–$685M,** reflecting confidence in AI product upsell, international expansion, and enterprise wins. However, they flagged emerging tariff risks and ongoing cost headwinds.
- **Risks include tariff impacts in H2 2025, elevated stock-based compensation, and negative cash flows,** which could pressure margins and near-term profitability. **Opportunities remain significant** with 70% of customers on basic plans and strong international/enterprise momentum.
- **Catalyst watch:** Investor focus will be on H2 tariff impacts, margin stabilization, and the pace of AI product adoption and international expansion.

---

## Performance Snapshot

| Metric                | Reported | Consensus | Surprise | YoY Change |
|-----------------------|----------|-----------|----------|------------|
| Revenue               | $669M    | N/A       | Beat     | +33%       |
| EPS                   | N/A      | N/A       | N/A      | N/A        |
| Software & Services   | +39% YoY |           |          |            |
| Connected Devices     | +29% YoY |           |          |            |
| Adjusted Gross Margin | 63.3%    |           | +20 bps  |            |
| Software Margin       | 75.6%    |           | +150 bps |            |
| Operating Cash Flow   | –$92M    |           |          |            |
| Free Cash Flow        | –$115M   |           |          |            |

---

## Earnings Quality

Axon Enterprise’s Q2 2025 revenue growth was broad-based, with both Software & Services and Connected Devices posting strong double-digit gains. The revenue mix continues to shift toward higher-margin software, as evidenced by the 150 bps YoY improvement in Software & Services margin (to 75.6%). However, overall gross margin declined 40 bps, reflecting cost pressures from increased R&D, SG&A, and labor. Heavy stock-based compensation ($139M) was a key driver of the operating loss and negative cash flows, partially offset by internal AI-driven cost efficiencies and software margin gains.

---

## Management Commentary & Guidance

Management maintained a **bullish outlook**, citing record bookings, robust international momentum, and rapid adoption of Axon’s AI-powered report writing tool. The company raised full-year revenue guidance to $2.65B–$2.73B and adjusted EBITDA to $665M–$685M, exceeding or matching Street expectations. Management’s optimism is grounded in strong underlying demand, AI product upsell, and international expansion, but they also acknowledged emerging tariff risks for H2 2025 and the ongoing impact of elevated stock-based compensation.

---

## Key Risks

- **Tariff impacts** in H2 2025 could pressure margins and disrupt supply chains.
- **High stock-based compensation** is weighing on operating income and cash flows.
- **Negative operating and free cash flows** highlight near-term cost challenges.
- **Regulatory and demand-side risks** remain, particularly as Axon expands internationally.

---

## Expected Market Reaction

Analyst and investor sentiment is likely to be **bullish** on the back of strong revenue growth, raised guidance, and strategic AI/international initiatives. However, concerns about margin pressures, negative cash flows, and tariff risks may temper near-term enthusiasm and keep valuation in check.

---

## Final Takeaway

**Q2 2025 was a strong quarter for Axon Enterprise, with clear evidence of robust demand, successful software transition, and strategic execution.** The market may be underappreciating Axon’s long-term upsell and international growth potential, especially in high-margin software. However, near-term risks from tariffs, cost inflation, and negative cash flows are not fully priced in. 

**Upcoming catalysts:**  
- H2 2025 tariff impact and margin stabilization  
- Acceleration in AI product adoption and international expansion

Investors should balance Axon’s compelling growth story with vigilance on cost and margin trends as the company navigates a dynamic operating environment.

Axon (AXON): Growth Outpaces Margin Pressures

Axon Enterprise is set for strong Q2 FY2025 results, with accelerating revenue, margin expansion, and underestimated AI-driven efficiency likely to drive upside versus consensus.

# Axon Enterprise Q2 FY2025 Earnings Outlook: Innovation Momentum, Margin Leverage, and the Underestimated AI Upside

## Executive Summary

We are **bullish** on Axon Enterprise’s Q2 FY2025 earnings outlook, driven by robust operational KPIs and management’s upwardly revised guidance. **Q1 FY2025 revenue of $603.6M** (+32% YoY) and a **34% YoY increase in ARR to $1.1B** signal strong demand continuity. The company’s **raised full-year revenue guidance to $2.60B–$2.70B** and improved gross margins (60.6%) point to further operating leverage in Q2. However, the market may be underestimating the near-term margin upside from Axon’s accelerated AI and software investments, which are poised to scale faster than anticipated. The key risk remains cost discipline amid ongoing R&D and stock-based compensation growth.

## Recent Trends Signal What’s Next

Axon’s last two quarters have established a clear trajectory of accelerating top-line growth and margin improvement. **Q1 FY2025 revenue grew 32% YoY to $603.6M**, with both Connected Devices and Software & Services segments posting double-digit gains. Gross margin expanded to **60.6%** (from 58.1% in Q4 FY2024), led by hardware margin improvement (from 43.7% to 50.1%). Operating margin, while still slightly negative at –1.4%, is stabilizing as operating leverage builds.

### Revenue, Margin, and EPS Trend Table

| Quarter      | Revenue ($M) | Gross Margin (%) | Operating Margin (%) | EPS ($) |
|--------------|--------------|------------------|----------------------|---------|
| Q2 FY2024    | 474.6        | 58.2             | 2.1                  | 0.80    |
| Q3 FY2024    | 518.8        | 59.0             | 1.5                  | 0.92    |
| Q4 FY2024    | 547.2        | 58.1             | 0.3                  | 0.95    |
| Q1 FY2025    | 603.6        | 60.6             | –1.4                 | 0.89    |

**Trend:** Revenue and gross margin are rising sequentially, while operating margin is stabilizing after a dip due to higher investment.

## Management’s Forward Tone and Positioning

Management’s Q1 FY2025 commentary was **confidently optimistic**, emphasizing “record” demand and “momentum” in both product and software rollouts. CEO Rick Smith stated, **“We’re seeing strong adoption of TASER 10 and our AI-powered Axon Assistant, which are driving new bookings and ARR.”** This is a notable shift from the more cautious tone in Q4 FY2024, where management highlighted “cost headwinds” and “macro uncertainty.” The Q1 call also included a clear signal: **“We are raising our full-year revenue and adjusted EBITDA guidance, reflecting our confidence in execution and demand visibility.”** The absence of planned price increases, despite cost inflation, suggests management is betting on volume and innovation to sustain margin expansion.

## KPI Trends & Upcoming Quarter Drivers

The most relevant KPIs for Q2 FY2025 are **Annual Recurring Revenue (ARR), future contracted bookings backlog, and inventory levels**.

### KPI Movement Table

| KPI                        | Q1 FY2024 | Q4 FY2024 | Q1 FY2025 | YoY Change | QoQ Change |
|----------------------------|-----------|-----------|-----------|------------|------------|
| ARR ($B)                   | 0.82      | 1.03      | 1.10      | +34%       | +6.8%      |
| Backlog ($B)               | 7.0       | 9.2       | 9.9       | +41%       | +7.6%      |
| Inventory ($M)             | 210.4     | 256.1     | 279.7     | +33%       | +9.2%      |

- **ARR and Backlog:** Both metrics are accelerating, supporting sustained revenue growth and visibility into Q2 and beyond.
- **Inventory:** The build-up suggests supply chain resilience but could pressure working capital if demand softens unexpectedly.

## Missed by the Street

A subtle but critical signal is management’s **emphasis on AI and software investments** as a near-term margin lever. While the Street is focused on cost pressures, the company’s commentary—**“We are excited by the early productivity gains from our AI initiatives”**—implies that these investments are already contributing to efficiency and could drive upside to consensus margin expectations. Additionally, the lack of planned price increases, despite robust demand, suggests Axon is prioritizing market share and long-term ARR growth over short-term margin maximization.

## Scenarios for the Upcoming Quarter

### Q2 FY2025 Scenario Table

| Scenario | Revenue ($M) | EPS ($) | Operating Margin (%) | Key Assumptions                                                                 |
|----------|--------------|---------|----------------------|---------------------------------------------------------------------------------|
| Bull     | 620          | 1.05    | 2.0                  | Continued product momentum, robust ARR/backlog growth, easing FX/input pressures |
| Base     | 605          | 0.95    | 1.0                  | Stable demand, operational efficiency, moderate cost inflation                   |
| Bear     | 595          | 0.85    | –0.5                 | Slower adoption, higher input/FX costs, inventory overhang                       |

**Most Likely:** The **Base case** is most probable, given current ARR and backlog trends, management’s raised guidance, and stable demand signals. However, the Bull case is increasingly plausible if AI-driven efficiency gains materialize faster than expected.

## Appendix – Data Tables & Management Quotes

### Quarterly Revenue, EPS, and Margin Trends

| Quarter      | Revenue ($M) | EPS ($) | Gross Margin (%) | Operating Margin (%) |
|--------------|--------------|---------|------------------|----------------------|
| Q2 FY2024    | 474.6        | 0.80    | 58.2             | 2.1                  |
| Q3 FY2024    | 518.8        | 0.92    | 59.0             | 1.5                  |
| Q4 FY2024    | 547.2        | 0.95    | 58.1             | 0.3                  |
| Q1 FY2025    | 603.6        | 0.89    | 60.6             | –1.4                 |

### KPI Movement Table

| KPI                        | Q1 FY2024 | Q4 FY2024 | Q1 FY2025 | YoY Change | QoQ Change |
|----------------------------|-----------|-----------|-----------|------------|------------|
| ARR ($B)                   | 0.82      | 1.03      | 1.10      | +34%       | +6.8%      |
| Backlog ($B)               | 7.0       | 9.2       | 9.9       | +41%       | +7.6%      |
| Inventory ($M)             | 210.4     | 256.1     | 279.7     | +33%       | +9.2%      |

### Key Management Quotes

1. **“We’re seeing strong adoption of TASER 10 and our AI-powered Axon Assistant, which are driving new bookings and ARR.”**  
   *Q1 2025 Earnings Call*  
   *Implies robust demand and early success of new product launches.*

2. **“We are raising our full-year revenue and adjusted EBITDA guidance, reflecting our confidence in execution and demand visibility.”**  
   *Q1 2025 Earnings Call*  
   *Signals management’s conviction in sustained growth and margin improvement.*

3. **“No planned price increases for the remainder of the year.”**  
   *Q1 2025 Earnings Call*  
   *Suggests focus on volume and innovation to drive margin, not pricing.*

4. **“We are excited by the early productivity gains from our AI initiatives.”**  
   *Q1 2025 Earnings Call*  
   *Indicates that AI investments are already yielding operational benefits.*

5. **“Tariffs could reduce our EBITDA margin by approximately 50 basis points if implemented.”**  
   *Q1 2025 Earnings Call*  
   *Highlights a specific external risk to margin guidance.*

6. **“We continue to invest in R&D and talent to support our long-term innovation roadmap.”**  
   *Q1 2025 Earnings Call*  
   *Points to ongoing cost pressures but also future growth drivers.*

7. **“We’re seeing early signs of normalization in demand from federal customers.”**  
   *Q1 2025 Earnings Call*  
   *Suggests stabilization in a previously volatile end market.*

---

**Conclusion:**  
Axon Enterprise enters Q2 FY2025 with strong operational momentum, clear management confidence, and underappreciated upside from AI-driven efficiency. While cost pressures and macro risks persist, the company’s robust ARR and backlog growth, combined with margin expansion, position it for another quarter of outperformance. Investors should monitor execution on AI/software scaling and inventory management as key swing factors for the quarter.

Axon (AXON): Q2 AI Upside and Margin Expansion